Read more
Senate HELP Committee Plans 11/18 Vote on Overton FDA Nomination
The Senate Health, Education, Labor and Pensions (HELP) Committee has announced an 11/18 vote on President Trump's nomination of Heidi Overton as FDA commissioner, setting up a potentially contentious confirmation effort before Democrats take control of the Senate in January. The White House is reportedly preparing an
Confirm Overton Now: Kathleen Jaeger
Among the many issues facing Congress before the end of the year, it should confirm Heidi Overton as FDA commissioner, according to healthcare strategy and consulting firm Medsecurean founder and CEO Kathleen Jaeger, who previously was CEO of the Generic Pharmaceutical Association (now the Association for Accessible Medicines). Writing in
FDA Probe Leads to Arrest of Canadian Drug Importation Executive
A senior executive of Canadian prescription drug supplier CANARX has been arrested on federal charges involving an alleged scheme to illegally import prescription drugs into the U.S., according to CNBC. John Thomas Howard, the company's treasurer and a director, was arrested Sunday on charges including smuggling, conspiracy,
Senators Press HHS on Prediction Markets Tied to Drug Approvals, Clinical Trials
Two Democratic senators are seeking information from HHS about safeguards against insider trading and other risks associated with prediction markets that allow investors to wager on clinical trial results and FDA drug approval decisions. Sens. Angela Alsobrooks (D-MD) and Ron Wyden (D-OR) raised the concerns in an 11/